1
|
Luppi PH, Chancel A, Malcey J, Cabrera S, Fort P, Maciel RM. Which structure generates paradoxical (REM) sleep: The brainstem, the hypothalamus, the amygdala or the cortex? Sleep Med Rev 2024; 74:101907. [PMID: 38422648 DOI: 10.1016/j.smrv.2024.101907] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/18/2023] [Revised: 12/31/2023] [Accepted: 01/19/2024] [Indexed: 03/02/2024]
Abstract
Paradoxical or Rapid eye movement (REM) sleep (PS) is a state characterized by REMs, EEG activation and muscle atonia. In this review, we discuss the contribution of brainstem, hypothalamic, amygdalar and cortical structures in PS genesis. We propose that muscle atonia during PS is due to activation of glutamatergic neurons localized in the pontine sublaterodorsal tegmental nucleus (SLD) projecting to glycinergic/GABAergic pre-motoneurons localized in the ventro-medial medulla (vmM). The SLD PS-on neurons are inactivated during wakefulness and slow-wave sleep by PS-off GABAergic neurons localized in the ventrolateral periaqueductal gray (vPAG) and the adjacent deep mesencephalic reticular nucleus. Melanin concentrating hormone (MCH) and GABAergic PS-on neurons localized in the posterior hypothalamus would inhibit these PS-off neurons to initiate the state. Finally, the activation of a few limbic cortical structures during PS by the claustrum and the supramammillary nucleus as well as that of the basolateral amygdala would also contribute to PS expression. Accumulating evidence indicates that the activation of these limbic structures plays a role in memory consolidation and would communicate to the PS-generating structures the need for PS to process memory. In summary, PS generation is controlled by structures distributed from the cortex to the medullary level of the brain.
Collapse
Affiliation(s)
- Pierre-Hervé Luppi
- INSERM, U1028, CNRS, UMR5292, Lyon Neuroscience Research Center, SLEEP Team "Physiopathologie des réseaux neuronaux responsables du cycle veille-sommeil", Lyon, France; University Claude Bernard, Lyon 1, Lyon, France.
| | - Amarine Chancel
- INSERM, U1028, CNRS, UMR5292, Lyon Neuroscience Research Center, SLEEP Team "Physiopathologie des réseaux neuronaux responsables du cycle veille-sommeil", Lyon, France; University Claude Bernard, Lyon 1, Lyon, France
| | - Justin Malcey
- INSERM, U1028, CNRS, UMR5292, Lyon Neuroscience Research Center, SLEEP Team "Physiopathologie des réseaux neuronaux responsables du cycle veille-sommeil", Lyon, France; University Claude Bernard, Lyon 1, Lyon, France
| | - Sébastien Cabrera
- INSERM, U1028, CNRS, UMR5292, Lyon Neuroscience Research Center, SLEEP Team "Physiopathologie des réseaux neuronaux responsables du cycle veille-sommeil", Lyon, France; University Claude Bernard, Lyon 1, Lyon, France
| | - Patrice Fort
- INSERM, U1028, CNRS, UMR5292, Lyon Neuroscience Research Center, SLEEP Team "Physiopathologie des réseaux neuronaux responsables du cycle veille-sommeil", Lyon, France; University Claude Bernard, Lyon 1, Lyon, France
| | - Renato M Maciel
- INSERM, U1028, CNRS, UMR5292, Lyon Neuroscience Research Center, SLEEP Team "Physiopathologie des réseaux neuronaux responsables du cycle veille-sommeil", Lyon, France; University Claude Bernard, Lyon 1, Lyon, France
| |
Collapse
|
2
|
Kumbar J, Ganesh CB. Melanin-concentrating hormone interferes with the hypothalamic-pituitary-gonad axis in the Mozambique tilapia. Comp Biochem Physiol A Mol Integr Physiol 2021; 265:111122. [PMID: 34838935 DOI: 10.1016/j.cbpa.2021.111122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2021] [Revised: 11/17/2021] [Accepted: 11/22/2021] [Indexed: 11/24/2022]
Abstract
This study was conducted to elucidate the influence of melanin-concentrating hormone (MCH) along the reproductive-axis in the female tilapia Oreochromis mossambicus. Administration of MCH (4 μg / 0.1 ml saline) for 22 days resulted in significantly lower gonadosomatic index compared to controls. Significant reduction in the mean numbers of follicles at different stages of development such as previtellogenic (stages I-III), vitellogenic (stage IV) and preovulatory (stage V) follicles was observed in MCH-treated fish compared with controls. On the other hand, the rate of atresia was significantly higher in follicles at stages II, III and IV in MCH-treated fish. In addition, in the pituitary gland, sparsely labelled gonadotropin releasing hormone (GnRH)-immunoreactive fibres were observed in MCH-treated fish in contrast to their intense labelling in controls. The serum level of luteinizing hormone (LH) showed significant decrease, but the serum cortisol level rose significantly following MCH treatment compared to those of controls. Collectively, these results indicate for the first time, that MCH treatment blocks follicular development during the ovarian cycle, possibly through the suppression of GnRH-LH axis in fish. The results also indicate that MCH may activate the stress-axis pathway in fish.
Collapse
Affiliation(s)
- Jyoti Kumbar
- Neuroendocrinology Research Laboratory, Department of Studies in Zoology, Karnatak University, Dharwad 580 003, India
| | - C B Ganesh
- Neuroendocrinology Research Laboratory, Department of Studies in Zoology, Karnatak University, Dharwad 580 003, India.
| |
Collapse
|
3
|
Sanathara N, Alhassen L, Marmouzi I, Khoudari M, Phan J, Alhassen W, Civelli O, Alachkar A. Oxytocin-MCH circuit regulates monosynaptic inputs to MCH neurons and modulates social recognition memory. Neuropharmacology 2020; 184:108423. [PMID: 33290754 DOI: 10.1016/j.neuropharm.2020.108423] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Revised: 11/24/2020] [Accepted: 12/01/2020] [Indexed: 01/05/2023]
Abstract
Oxytocin regulates social behaviors and has been linked to the etiology of autism and schizophrenia. Oxytocin and another hypothalamic neuropeptide, melanin concentrating hormone (MCH), share several physiological actions such as emotion, social behavior and recognition, maternal care, sexual behavior and stress, which suggests that these two systems may interact, however, how they would do it is not known. Here, we study the interactions between the oxytocin and MCH systems in behaviors related to autism and schizophrenia. Specifically, we examined the synaptic inputs of the oxytocin-to the MCH neurons. We selectively deleted oxytocin receptors (OXTR) from MCH neurons (OXTR-cKO mice) using a Cre/loxP recombinase-technology, and used rabies-mediated circuit mapping technique to reveal the changes in the direct monosynaptic inputs to MCH neurons. We examined the behavioral responses of OXTR-cKO mice. Deletion of OXTR from MCH neurons induced a significant decrease in the primary inputs received by MCH neurons from the paraventricular nucleus and the lateral hypothalamus, and from the nucleus accumbens and ventral tegmental area. While OXTR-cKO mice exhibited similar social interactions as control mice, they displayed significantly impaired social recognition memory and increased stereotypic behavior. Our study identifies a selective role for the oxytocin-MCH pathway in social recognition memory and stereotyped behavior that are relevant to psychiatric disorders such as schizophrenia and autism, and warrant further investigation of this circuit to uncover potential benefit of targeting the oxytocin-MCH circuit as a novel therapeutic target for treatment of social recognition deficits in these two disorders.
Collapse
Affiliation(s)
- Nayna Sanathara
- Departments of Pharmaceutical Sciences, School of Pharmacy, University of California-Irvine, CA, 92697, USA
| | - Lamees Alhassen
- Departments of Pharmaceutical Sciences, School of Pharmacy, University of California-Irvine, CA, 92697, USA
| | - Ilias Marmouzi
- Departments of Pharmaceutical Sciences, School of Pharmacy, University of California-Irvine, CA, 92697, USA
| | - Mohammad Khoudari
- Departments of Pharmaceutical Sciences, School of Pharmacy, University of California-Irvine, CA, 92697, USA
| | - Joseph Phan
- Departments of Pharmaceutical Sciences, School of Pharmacy, University of California-Irvine, CA, 92697, USA
| | - Wedad Alhassen
- Departments of Pharmaceutical Sciences, School of Pharmacy, University of California-Irvine, CA, 92697, USA
| | - Olivier Civelli
- Departments of Pharmaceutical Sciences, School of Pharmacy, University of California-Irvine, CA, 92697, USA; Department of Developmental and Cell Biology, School of Biological Sciences, University of California-Irvine, CA, 92697, USA
| | - Amal Alachkar
- Departments of Pharmaceutical Sciences, School of Pharmacy, University of California-Irvine, CA, 92697, USA; Institute for Genomics and Bioinformatics, School of Information and Computer Sciences, University of California-Irvine, CA, 92697, USA.
| |
Collapse
|
4
|
Sharma R, Sharma A, Sahota P, Thakkar MM. Orexin gene expression is downregulated in alcohol dependent rats during acute alcohol withdrawal. Neurosci Lett 2020; 739:135347. [PMID: 33011195 DOI: 10.1016/j.neulet.2020.135347] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/29/2020] [Revised: 08/26/2020] [Accepted: 08/27/2020] [Indexed: 01/14/2023]
Abstract
Alcohol use disorders (AUD) are chronic relapsing brain disorder characterized by compulsive and heavy alcohol consumption. During acute withdrawal, patients with AUD display excessive daytime sleepiness, a condition linked to serious life-threatening complications, however, the mechanism is not known. Orexin and melanin-concentrating hormone (MCH) are the two hypothalamic neuropeptides that regulate many behaviors including sleep-wakefulness, and alcohol consumption, reinforcement, and reinstatement. Importantly, loss of orexin neurons causes narcolepsy, a severe sleep disorder with excessive daytime sleepiness. Does acute alcohol withdrawal reduce orexin gene expression? To investigate this, male Sprague-Dawley rats were divided in two groups: Rats were either administered with alcohol, mixed with infant formula (alcohol group) or control mixture containing water and infant formula (Controls) by gastric intubation every 8 h for 4 days using Majchrowicz's chronic binge drinking protocol. The doses of alcohol were adjusted depending on degree of intoxication, exhibited by animals, prior to each dose. The animals were euthanized after 12 h of last alcohol/water administration. During withdrawal, the hypothalamus was rapidly dissected out, and the expressions of orexin and MCH genes were examined by Real-time PCR. There was a significant reduction in orexin gene expression in rats subjected to alcohol withdrawal as compared to controls. No such change was observed in the MCH gene expression. These results suggest that downregulation of orexin gene expression may be a possible mechanism responsible for excessive daytime sleepiness associated with alcohol withdrawal in patients with AUD.
Collapse
Affiliation(s)
- Rishi Sharma
- Harry S. Truman Memorial Veterans Hospital and Department of Neurology, University of Missouri, Columbia, MO, 65201, United States
| | - Abhilasha Sharma
- Harry S. Truman Memorial Veterans Hospital and Department of Neurology, University of Missouri, Columbia, MO, 65201, United States
| | - Pradeep Sahota
- Harry S. Truman Memorial Veterans Hospital and Department of Neurology, University of Missouri, Columbia, MO, 65201, United States
| | - Mahesh M Thakkar
- Harry S. Truman Memorial Veterans Hospital and Department of Neurology, University of Missouri, Columbia, MO, 65201, United States.
| |
Collapse
|
5
|
Helal MA, Chittiboyina AG, Avery MA. Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening. Bioorg Med Chem Lett 2019; 29:126741. [PMID: 31678007 DOI: 10.1016/j.bmcl.2019.126741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/13/2019] [Revised: 10/01/2019] [Accepted: 10/03/2019] [Indexed: 10/25/2022]
Abstract
MCH receptor is a G protein-coupled receptor with two subtypes R1 and R2. Many studies have demonstrated the role of MCH-R1 in feeding and energy homeostasis. It has been proven that oral administration of small molecule MCH-R1 antagonists significantly reduces food intake and causes a dose-dependent weight loss. In this study, two ligand-based pharmacophores were developed and validated based on recently published MCH-R1 antagonists with diverse structures. Successful pharmacophores had one hydrogen bond acceptor, one positive ionizable, one ring aromatic and two or three hydrophobic groups. These 3D-QSAR models were used for virtual screening of the ZINC chemical database resulting in the identification of nine compounds with more than 50% displacement of radiolabeled MCH at a 20 μM concentration. Moreover, four of these compounds showed antagonistic activities in Aequorin functional assay, including MH-3 which is the first MCH-R1 antagonist based on a diazaspiro[4.5]decane scaffold. The most active compounds were also docked into our previously published MCH-R1 homology model to gain insights into their binding determinants. These compounds could represent a viable starting scaffold for the design of potent MCH-R1 antagonists with improved pharmacokinetic properties as an effective treatment for obesity.
Collapse
Affiliation(s)
- Mohamed A Helal
- University of Science and Technology, Biomedical Sciences Program, Zewail City of Science and Technology, October Gardens, 6th of October, Giza 12578, Egypt; Medicinal Chemistry Department, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt.
| | - Amar G Chittiboyina
- National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, United States
| | - Mitchell A Avery
- Department of BioMolecular Sciences, School of Pharmacy, University of Mississippi, University, MS 38677, United States
| |
Collapse
|
6
|
Alhassen L, Phan A, Alhassen W, Nguyen P, Lo A, Shaharuddin H, Sanathara N, Civelli O, Alachkar A. The role of Olfaction in MCH-regulated spontaneous maternal responses. Brain Res 2019; 1719:71-76. [PMID: 31121161 DOI: 10.1016/j.brainres.2019.05.021] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2019] [Revised: 05/03/2019] [Accepted: 05/18/2019] [Indexed: 01/27/2023]
Abstract
Melanin concentrating hormone (MCH) is involved in the initiation of maternal behavior during the postpartum period. Virgin females also display some aspects of maternal care independent of the hormonal and neurochemical changes associated with pregnancy and parturition. Maternal behavior in virgin females is triggered by pups-generated chemosensory signals. We therefore examined the role of MCH in maternal-related behaviors in virgin mice and whether it involves chemosensory mechanisms. We used mice with germline knock-out of MCH receptor (MCHR1 KO) and mice with conditional ablation of MCH neurons (MCH cKO) using Cre-inducible diphtheria toxin (iDTR) system. We report that germline deletion of MCHR1 and ablation of MCH neurons impair spontaneous maternal behavior that is induced upon pups' exposure. The latency and duration to retrieve pups by MCHR1 KO and MCH cKO mice are longer than their control littermate mice. In support of this finding, we found that in the three-chamber social test, both MCHR1 KO and MCH cKO mice display a lack of interest in interacting with pups. Strikingly, however, we found that while MCHR1 KO mice were unable to detect pups' chemosensory signals and displayed impairment in general olfactory discrimination, MCH cKO mice exhibited normal olfactory function. Our findings indicate that the lack of MCHR1 or of normal MCH levels causes defects in maternal behavior in non-sensitized virgin mice, and that disruption of the olfactory signaling might not count for these defects.
Collapse
Affiliation(s)
- Lamees Alhassen
- Department of Pharmacology, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States
| | - Alvin Phan
- Department of Pharmacology, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States
| | - Wedad Alhassen
- Department of Pharmacology, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States
| | - Paul Nguyen
- Department of Pharmacology, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States
| | - Alice Lo
- Department of Pharmacology, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States
| | - Hanan Shaharuddin
- Department of Pharmacology, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States
| | - Nayna Sanathara
- Department of Pharmacology, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States
| | - Olivier Civelli
- Department of Pharmacology, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States; Department of Pharmaceutical Sciences, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States; Department of Developmental and Cell Biology, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States
| | - Amal Alachkar
- Department of Pharmaceutical Sciences, School of Medicine, 369 Med Surge II, University of California, Irvine, Irvine, CA 92697-4625, United States.
| |
Collapse
|
7
|
Fujimoto M, Fukuda S, Sakamoto H, Takata J, Sawamura S. Neuropeptide glutamic acid-isoleucine (NEI)-induced paradoxical sleep in rats. Peptides 2017; 87:28-33. [PMID: 27845162 DOI: 10.1016/j.peptides.2016.11.007] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/30/2016] [Revised: 11/10/2016] [Accepted: 11/10/2016] [Indexed: 01/10/2023]
Abstract
Neuropeptideglutamic acid-isoleucine (NEI) as well as melanin concentrating hormone (MCH) is cleaved from the 165 amino acid protein, prepro-melanin concentrating hormone (prepro-MCH). Among many physiological roles of MCH, we demonstrated that intracerebroventricular (icv) injection of MCH induced increases in REM sleep episodes as well as in non REM sleep episodes. However, there are no studies on the effect of NEI on the sleep-wake cycle. As for the sites of action of MCH for induction of REM sleep, the ventrolateral periaqueductal gray (vlPAG) has been reported to be one of its site of action. Although MCH neurons contain NEI, GABA, MCH, and other neuropeptides, we do not know which transmitter(s) might induce REM sleep by acting on the vlPAG. Thus, we first examined the effect of icv injection of NEI on the sleep-wake cycle, and investigated how microinjection of either NEI, MCH, or GABA into the vlPAG affected REM sleep in rats. Icv injection of NEI (0.61μg/5μl: n=7) significantly increased the time spent in REM episodes compared to control (saline: 5μl; n=6). Microinjection of either NEI (61ng/0.2μl: n=7), MCH (100ng/0.2μl: n=6) or GABA (250mM/0.2μl: n=7) into the vlPAG significantly increased the time spent in REM episodes and the AUC. Precise hourly analysis of REM sleep also revealed that after those microinjections, NEI and MCH increased REM episodes at the latter phase, compared to GABA which increased REM episodes at the earlier phase. This result suggests that NEI and MCH may induce sustained REM sleep, while GABA may initiate REM sleep. In conclusion, our findings demonstrate that NEI, a cleaved peptide from the same precursor, prepro-MCH, as MCH, induce REM sleep at least in part through acting on the vlPAG.
Collapse
Affiliation(s)
- Moe Fujimoto
- Department of Anesthesiology, Teikyo University School of Medicine, Japan.
| | - Satoru Fukuda
- Department of Anesthesiology, Showa University School of Medicine, Japan
| | - Hidetoshi Sakamoto
- Department of Anesthesiology, Teikyo University School of Medicine, Japan
| | - Junko Takata
- Department of Anesthesiology, Teikyo University School of Medicine, Japan
| | - Shigehito Sawamura
- Department of Anesthesiology, Teikyo University School of Medicine, Japan
| |
Collapse
|
8
|
Herrera CG, Ponomarenko A, Korotkova T, Burdakov D, Adamantidis A. Sleep & metabolism: The multitasking ability of lateral hypothalamic inhibitory circuitries. Front Neuroendocrinol 2017; 44:27-34. [PMID: 27884682 DOI: 10.1016/j.yfrne.2016.11.002] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/20/2016] [Revised: 11/18/2016] [Accepted: 11/19/2016] [Indexed: 02/01/2023]
Abstract
The anatomical and functional mapping of lateral hypothalamic circuits has been limited by the numerous cell types and complex, yet unclear, connectivity. Recent advances in functional dissection of input-output neurons in the lateral hypothalamus have identified subset of inhibitory cells as crucial modulators of both sleep-wake states and metabolism. Here, we summarize these recent studies and discuss the multi-tasking functions of hypothalamic circuitries in integrating sleep and metabolism in the mammalian brain.
Collapse
Affiliation(s)
- Carolina Gutierrez Herrera
- Department of Neurology and Department of Clinical Research, Inselspital University Hospital, University of Bern, Bern, Switzerland; Department of Psychiatry, McGill University, Montreal, QC, Canada
| | - Alexey Ponomarenko
- Leibniz Institute for Molecular Pharmacology (FMP)/NeuroCure Cluster of Excellence, Berlin, Germany
| | - Tatiana Korotkova
- Leibniz Institute for Molecular Pharmacology (FMP)/NeuroCure Cluster of Excellence, Berlin, Germany
| | - Denis Burdakov
- The Francis Crick Institute, Mill Hill Laboratory, London NW7 1AA, UK; Department of Developmental Neurobiology, King's College London, London WC2R 2LS, UK
| | - Antoine Adamantidis
- Department of Neurology and Department of Clinical Research, Inselspital University Hospital, University of Bern, Bern, Switzerland; Department of Psychiatry, McGill University, Montreal, QC, Canada.
| |
Collapse
|
9
|
Alachkar A, Alhassen L, Wang Z, Wang L, Onouye K, Sanathara N, Civelli O. Inactivation of the melanin concentrating hormone system impairs maternal behavior. Eur Neuropsychopharmacol 2016; 26:1826-1835. [PMID: 27617778 PMCID: PMC5929110 DOI: 10.1016/j.euroneuro.2016.08.014] [Citation(s) in RCA: 25] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/20/2016] [Revised: 08/05/2016] [Accepted: 08/24/2016] [Indexed: 01/22/2023]
Abstract
In order to prepare the mother for the demands of pregnancy and lactation, the maternal brain is subjected to a number of adaptations. Maternal behaviors are regulated by complex neuronal interactions. Here, we show that the melanin concentrating hormone (MCH) system is an important regulator of maternal behaviors. First, we report that melanin concentrating hormone receptor 1 knockout (MCHR1 KO) mice display a disruption of maternal behavior. Early postpartum MCHR1 KO females exhibit poor nesting, deficits in pup retrieval and maternal aggression. In addition, ablation of MCH receptors results in decreased milk production and prolactin mRNA levels. Then we show that these results are in line with those obtained in wild type mice (WT) treated with the specific MCHR1 antagonist GW803430. Furthermore, following pups retrieval, MCHR1 KO mice display a lower level of Fos expression than WT mice in the ventral tegmental area, and nucleus accumbens. With the progression of the lactation period, however, the MCHR1 KO mice improve maternal care towards their pups. This is manifested by an increase in the pups׳ survival rate and the decrease in pups׳ retrieval time beyond the second day after parturition. In conclusion, we show that the MCH system plays a significant role in the initiation of maternal behavior. In this context, MCH may play a role in integrating information from multiple sources, and connecting brain reward, homeostatic and regulatory systems.
Collapse
Affiliation(s)
- Amal Alachkar
- Departments of Pharmacology, School of Medicine, University of California, 369 Med Surge II, Irvine, CA 92697-4625, United States.
| | - Lamees Alhassen
- Departments of Pharmacology, School of Medicine, University of California, 369 Med Surge II, Irvine, CA 92697-4625, United States
| | - Zhiwei Wang
- Departments of Pharmacology, School of Medicine, University of California, 369 Med Surge II, Irvine, CA 92697-4625, United States
| | - Lien Wang
- Departments of Pharmacology, School of Medicine, University of California, 369 Med Surge II, Irvine, CA 92697-4625, United States
| | - Kara Onouye
- Departments of Pharmacology, School of Medicine, University of California, 369 Med Surge II, Irvine, CA 92697-4625, United States
| | - Nayna Sanathara
- Departments of Pharmacology, School of Medicine, University of California, 369 Med Surge II, Irvine, CA 92697-4625, United States
| | - Olivier Civelli
- Departments of Pharmacology, School of Medicine, University of California, 369 Med Surge II, Irvine, CA 92697-4625, United States; Pharmaceutical Sciences, School of Medicine, University of California, 369 Med Surge II, Irvine, CA 92697-4625, United States; Developmental and Cell Biology, School of Medicine, University of California, 369 Med Surge II, Irvine, CA 92697-4625, United States
| |
Collapse
|
10
|
Geuzaine A, Tyhon A, Grisar T, Brabant C, Lakaye B, Tirelli E. Amphetamine reward in food restricted mice lacking the melanin-concentrating hormone receptor-1. Behav Brain Res 2014; 262:14-20. [PMID: 24412349 DOI: 10.1016/j.bbr.2013.12.052] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/14/2013] [Revised: 12/28/2013] [Accepted: 12/30/2013] [Indexed: 01/04/2023]
Abstract
Chronic food restriction (FR) and maintenance of low body weight have long been known to increase the rewarding and motor-activating effects of addictive drugs. However, the neurobiological mechanisms through which FR potentiates drug reward remain largely unknown. Melanin-concentrating hormone (MCH) signaling could be one of these mechanisms since this peptide is involved in energy homeostasis and modulates mesolimbic dopaminergic transmission. The purpose of the present study was to test this hypothesis by investigating the impact of FR on amphetamine reward in wild-type (WT) and knockout mice lacking the melanin-concentrating hormone receptor-1 (MCHR1-KO). The rewarding effects of amphetamine (0.75-2.25 mg/kg, i.p.) were measured with the conditioned place preference (CPP) technique. The food of the mice was restricted to maintain their body weight at 80-85% of their free-feeding (FF) weight throughout the entire CPP experiment. Locomotor activity of the animals was recorded during the conditioning sessions. Our results show that locomotion of all the food-restricted mice treated with saline or amphetamine increased over the sessions whatever the genotype. On the place preference test, the amplitude of CPP induced by 0.75 mg/kg amphetamine was higher in food restricted WT mice than in free-fed WT mice and food restricted MCHR1-KO mice. However, FR did not affect amphetamine reward in MCHR1-KO mice. The present results indicate that MCH signaling could be involved in the ability of FR to increase amphetamine-induced CPP.
Collapse
|